Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data

INTRODUCTION: Erenumab is indicated for migraine preventive treatment in adults. The objective of this study was to provide descriptive information on real-world use of erenumab including patient profile and treatment patterns. METHODS: We completed a retrospective review of US data (through May 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandler, David, Szekely, Christine, Aggarwal, Shivani, Cyprien, Lori, Bensink, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586283/
https://www.ncbi.nlm.nih.gov/pubmed/34533779
http://dx.doi.org/10.1007/s40122-021-00319-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586283/
https://www.ncbi.nlm.nih.gov/pubmed/34533779
http://dx.doi.org/10.1007/s40122-021-00319-z

Ejemplares similares